AR086519A1 - Procedimiento para producir hidrocloruro de epirubicina cristalino e hidrocloruro de epirubicina cristalino producido mediante este procedimiento - Google Patents
Procedimiento para producir hidrocloruro de epirubicina cristalino e hidrocloruro de epirubicina cristalino producido mediante este procedimientoInfo
- Publication number
- AR086519A1 AR086519A1 ARP120101808A ARP120101808A AR086519A1 AR 086519 A1 AR086519 A1 AR 086519A1 AR P120101808 A ARP120101808 A AR P120101808A AR P120101808 A ARP120101808 A AR P120101808A AR 086519 A1 AR086519 A1 AR 086519A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrocloride
- procedure
- crystalline
- epirubicin hydrochloride
- epirubicin
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 title 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 2
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 title 1
- 229960001904 epirubicin Drugs 0.000 title 1
- MWWSFMDVAYGXBV-FGBSZODSSA-N (7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydron;chloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-FGBSZODSSA-N 0.000 abstract 9
- 229960003265 epirubicin hydrochloride Drugs 0.000 abstract 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 abstract 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 abstract 6
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 abstract 4
- 238000004519 manufacturing process Methods 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 238000002425 crystallisation Methods 0.000 abstract 2
- 230000008025 crystallization Effects 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
- A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente se refiere a hidrocloruro de epirubicina cristalino y un procedimiento para su producción. El procedimiento para producir hidrocloruro de epirubicina cristalino comprende las etapas operativas de: (a) provisión de hidrocloruro de epirubicina, (b) producción de una mezcla que contiene el hidrocloruro de epirubicina provisto y al menos un alcohol seleccionado del grupo que comprende 1-butanol, 2-butanol y 1-pentanol, y (c) cristalización del hidrocloruro de epirubicina a partir de esta mezcla.Reivindicación 1: Procedimiento para producir hidrocloruro de epirubicina cristalino, caracterizado porque comprende las etapas operativas: (a) provisión de hidrocloruro de epirubicina, (b) producción de una mezcla que contiene el hidrocloruro de epirubicina provisto y al menos un alcohol seleccionado del grupo que comprende 1-butanol, 2-butanol y 1-pentanol, y (c) cristalización del hidrocloruro de epirubicina a partir de esta mezcla.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011103751A DE102011103751A1 (de) | 2011-05-31 | 2011-05-31 | Kristallisierung von Epirubicinhydrochlorid |
| US201161493034P | 2011-06-03 | 2011-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR086519A1 true AR086519A1 (es) | 2013-12-18 |
Family
ID=47173398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120101808A AR086519A1 (es) | 2011-05-31 | 2012-05-22 | Procedimiento para producir hidrocloruro de epirubicina cristalino e hidrocloruro de epirubicina cristalino producido mediante este procedimiento |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9657047B2 (es) |
| EP (1) | EP2714707B1 (es) |
| JP (2) | JP6014844B2 (es) |
| KR (1) | KR20140006092A (es) |
| CN (1) | CN103827129A (es) |
| AR (1) | AR086519A1 (es) |
| AU (1) | AU2012265238B2 (es) |
| DE (1) | DE102011103751A1 (es) |
| HR (1) | HRP20170329T1 (es) |
| HU (1) | HUE031795T2 (es) |
| PL (1) | PL2714707T3 (es) |
| RU (1) | RU2586117C2 (es) |
| TW (1) | TWI496789B (es) |
| WO (1) | WO2012163508A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2778171A1 (en) * | 2013-03-15 | 2014-09-17 | Synbias Pharma Ltd. | Crystalline monohydrate of epirubicin hydrochloride |
| CN104861014B (zh) * | 2015-06-03 | 2017-09-29 | 道中道（菏泽）制药有限公司 | 一种盐酸表阿霉素结晶的制备方法 |
| CN109384822B (zh) * | 2017-08-11 | 2021-08-03 | 鲁南制药集团股份有限公司 | 一种盐酸表柔比星晶型及其制备方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1506200A (en) | 1975-04-30 | 1978-04-05 | Farmaceutici Italia | Glycosides |
| US4345068A (en) | 1979-11-22 | 1982-08-17 | Farmitalia Carlo Erba S.P.A. | Process for the preparation of 4'-epidaunorubicin, 3',4'-diepidaunorubicin, their doxorubicin analogs, and intermediates used in said process |
| IT1155446B (it) | 1982-12-23 | 1987-01-28 | Erba Farmitalia | Procedimento per la purificazione di glucosidi antraciclinonici mediante adsobimento selettivo su resine |
| GB8426672D0 (en) | 1984-10-22 | 1984-11-28 | Erba Farmitalia | Pharmaceutical compositions |
| DE69609845T2 (de) * | 1996-12-16 | 2000-12-21 | Pharmachemie B.V., Haarlem | Verfahren zur Herstellung von Epirubicin oder Zusatzsalzen davon, von Daunorubicin |
| EP1034181B1 (en) | 1997-11-28 | 2006-01-11 | Dainippon Sumitomo Pharma Co., Ltd. | Crystalline amrubicin hydrochloride |
| ATE488524T1 (de) | 1997-12-05 | 2010-12-15 | Mercian Corp | Kristallines anthracyclin antibiotikum und seine herstellung |
| CZ20022332A3 (cs) * | 2000-01-07 | 2003-01-15 | Transform Pharmaceuticals, Inc. | Sestava vzorků |
| EP1638509B1 (en) * | 2003-07-02 | 2015-12-30 | Solux Corporation | Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| US20090099346A1 (en) | 2003-07-02 | 2009-04-16 | Victor Matvienko | Thermally stable crystalline epirubicin hydrochloride |
| US7388083B2 (en) * | 2005-03-07 | 2008-06-17 | Solux Corporation | Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics |
| US20070004653A1 (en) * | 2005-05-11 | 2007-01-04 | Roberto Arosio | Stable lyophilized anthracycline glycosides |
| US8802830B2 (en) * | 2005-12-20 | 2014-08-12 | Solux Corporation | Synthesis of epirubicin from 13-dihydrodaunorubicine |
| JP2007261976A (ja) * | 2006-03-28 | 2007-10-11 | Meiji Seika Kaisha Ltd | 抗腫瘍性アンスラサイクリン系抗生物質の製造法 |
| DK1990405T3 (da) | 2007-05-08 | 2017-11-06 | Provivo Oy | Genetisk modificerede stammer, der producerer anthracyclin-metabolitter anvendelige som kræftmedicin |
| JP5550644B2 (ja) | 2008-06-18 | 2014-07-16 | レクシコン ファーマシューティカルズ インコーポレイテッド | （１ｒ，２ｓ，３ｒ）−１−（２−（イソオキサゾール−３−イル）−１ｈ−イミダゾール−４−イル）ブタン−１，２，３，４−テトラオールの固体形態及びその使用方法 |
| EP2301943B1 (en) * | 2009-09-08 | 2014-01-08 | Heraeus Precious Metals GmbH & Co. KG | Crystallization of epidaunorubicin x HCI |
| KR101125460B1 (ko) * | 2010-03-24 | 2012-03-28 | 동아제약주식회사 | 에피루비신 염산염의 신규한 결정형 |
| CN102120750B (zh) * | 2011-01-30 | 2013-04-03 | 山东新时代药业有限公司 | 一种盐酸表柔比星的纯化方法 |
-
2011
- 2011-05-31 DE DE102011103751A patent/DE102011103751A1/de not_active Ceased
-
2012
- 2012-05-15 US US13/471,537 patent/US9657047B2/en active Active
- 2012-05-22 AR ARP120101808A patent/AR086519A1/es not_active Application Discontinuation
- 2012-05-25 CN CN201280026091.5A patent/CN103827129A/zh active Pending
- 2012-05-25 HU HUE12735774A patent/HUE031795T2/en unknown
- 2012-05-25 WO PCT/EP2012/002248 patent/WO2012163508A1/de not_active Ceased
- 2012-05-25 EP EP12735774.7A patent/EP2714707B1/de active Active
- 2012-05-25 HR HRP20170329TT patent/HRP20170329T1/hr unknown
- 2012-05-25 JP JP2014513078A patent/JP6014844B2/ja active Active
- 2012-05-25 AU AU2012265238A patent/AU2012265238B2/en active Active
- 2012-05-25 KR KR1020137031904A patent/KR20140006092A/ko not_active Ceased
- 2012-05-25 PL PL12735774T patent/PL2714707T3/pl unknown
- 2012-05-25 RU RU2013158684/04A patent/RU2586117C2/ru active
- 2012-05-29 TW TW101119194A patent/TWI496789B/zh active
-
2016
- 2016-05-18 JP JP2016099985A patent/JP2016175938A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012265238B2 (en) | 2016-05-12 |
| WO2012163508A1 (de) | 2012-12-06 |
| US9657047B2 (en) | 2017-05-23 |
| HRP20170329T1 (hr) | 2017-04-21 |
| TWI496789B (zh) | 2015-08-21 |
| US20120309948A1 (en) | 2012-12-06 |
| RU2586117C2 (ru) | 2016-06-10 |
| TW201302773A (zh) | 2013-01-16 |
| EP2714707A1 (de) | 2014-04-09 |
| HUE031795T2 (en) | 2017-08-28 |
| PL2714707T3 (pl) | 2017-06-30 |
| EP2714707B1 (de) | 2016-12-14 |
| JP6014844B2 (ja) | 2016-10-26 |
| JP2016175938A (ja) | 2016-10-06 |
| DE102011103751A1 (de) | 2012-12-06 |
| KR20140006092A (ko) | 2014-01-15 |
| JP2014515381A (ja) | 2014-06-30 |
| RU2013158684A (ru) | 2015-07-10 |
| AU2012265238A1 (en) | 2014-01-09 |
| CN103827129A (zh) | 2014-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017009561A (es) | Metodos de purificacion de cannabinoides, composiciones y kits de los mismos. | |
| ECSP18010065A (es) | Proceso para la producción de cannabidiol y delta-9-tetrahidrocannabinol | |
| BR112014010460A2 (pt) | composto, composição farmacêutica, processo para produzir uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica | |
| MX2012003048A (es) | Procesos para preparar derivados de bencil-benceno sustituidos con glucopiranosilo. | |
| BR112014013175A8 (pt) | composições de liberação prolongada baseadas em lipídios anfipáticos e processo para preparar comprimidos de composição de liberação prolongada | |
| AR061516A1 (es) | Composicion de rebaudiosido a y metodo para purificar el rebaudiosido a | |
| CR20190057A (es) | PROCEDIMIENTO DE PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS (Divisional 2014-0237) | |
| BR112014013098A2 (pt) | composições compreendendo ácidos graxos que têm 20 carbonos e métodos de produção e uso dos mesmos | |
| NI201200140A (es) | Hidrato del hidrocloruro de agomelatina y preparación de éste | |
| MX2012003637A (es) | Fabricacion de modulos solares. | |
| BR112015005404A2 (pt) | Formas polimórficas de enzalutamida e sua preparação | |
| AR090319A1 (es) | Biorrefineria integrada | |
| MX360062B (es) | Metodos de elaboracion de fenilacetato de l-ornitina. | |
| BR112013019520A2 (pt) | método para produção de 2,3-butanodiol por fermentação | |
| AR066612A1 (es) | Metodo para mejorar la calidad de los brotes de una planta | |
| BR112013022277A2 (pt) | método para produção de cadeia de açúcar contendo ácido siálico | |
| BR112014008401A2 (pt) | processo para a preparação de metoxi melonal | |
| BR112013016863A2 (pt) | processo para produzir um polistereterol | |
| CL2011000296A1 (es) | Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados. | |
| BR112014000901A2 (pt) | processo de separação | |
| EP2316811A4 (en) | PROCESS FOR PREPARING HYDROGENATED AROMATIC POLYCARBOXYLIC ACID | |
| BRPI1016020B8 (pt) | linha cirúrgica que compreende células e método de produção da mesma | |
| AR086519A1 (es) | Procedimiento para producir hidrocloruro de epirubicina cristalino e hidrocloruro de epirubicina cristalino producido mediante este procedimiento | |
| CU20120136A7 (es) | Hidrato del hidrobromuro de agomelatina y preparación de éste | |
| BR112015022859A2 (pt) | processo para fabricação de mono-hidrato trissódico gadofosveset |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |